View in EDS

Dual IL-2/IL-21 priming augments the anti-tumor function of CD16V-CAR/TRAIL-engineered NK cells in combination with monoclonal antibodies.

Saved in:
Bibliographic Details
Title: Dual IL-2/IL-21 priming augments the anti-tumor function of CD16V-CAR/TRAIL-engineered NK cells in combination with monoclonal antibodies.
Authors: Hwang I; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: ijhwang@slbigen.com., Lee J; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: jinulee@yonsei.ac.kr., Kim SW; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: swkim@slbigen.com., Sung YC; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, Republic of Korea. Electronic address: ycsung@postech.ac.kr.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2025 Aug; Vol. 189, pp. 118289. Date of Electronic Publication: 2025 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40561592
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dual IL-2/IL-21 priming augments the anti-tumor function of CD16V-CAR/TRAIL-engineered NK cells in combination with monoclonal antibodies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hwang+I%22">Hwang I</searchLink>; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: ijhwang@slbigen.com.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: jinulee@yonsei.ac.kr.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Yeonsu‑gu, Incheon, Republic of Korea. Electronic address: swkim@slbigen.com.<br /><searchLink fieldCode="AU" term="%22Sung+YC%22">Sung YC</searchLink>; SL BIGEN, Inc., Yeonsu-gu, Incheon, Republic of Korea; Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, Republic of Korea. Electronic address: ycsung@postech.ac.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228213295%22">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</searchLink> [Biomed Pharmacother] 2025 Aug; Vol. 189, pp. 118289. <i>Date of Electronic Publication: </i>2025 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>8213295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1950-6007 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207533322%22">07533322 </searchLink><i>NLM ISO Abbreviation: </i>Biomed Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40561592
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.biopha.2025.118289
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 118289
    Titles:
      – TitleFull: Dual IL-2/IL-21 priming augments the anti-tumor function of CD16V-CAR/TRAIL-engineered NK cells in combination with monoclonal antibodies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hwang I
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Kim SW
      – PersonEntity:
          Name:
            NameFull: Sung YC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1950-6007
          Numbering:
            – Type: volume
              Value: 189
          Titles:
            – TitleFull: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
              Type: main
ResultId 1